Activation of cells by hormones, growth factors or neurotransmitters leads to an increased production of inositol trisphosphate (InsP(3)) and, after activation of the InsP(3) receptor (InsP(3)R), to Ca2+ release from intracellular Ca2+ stores. The release of intracellular Ca2+ is characterised by a graded response when submaximal doses of agonists are used. The basic phenomenon, called ''quantal Ca2+ release'', is that even the maintained presence of a submaximal dose of agonist or of InsP(3) for long time periods (up to 20 min) provokes only a partial release of Ca2+. This partial, or quantal, release phenomenon is due to the fact that the initially very rapid InsP(3)-induced Ca2+ release eventually develops into a much slower release phase. Physiologically, quantal release allows the Ca2+ stores to function as increment detectors and to induce local Ca2+ responses. The basic mechanism for quantal release of Ca2+ is presently not known. Possible mechanisms to explain the quantal behaviour of InsP(3)-induced Ca2+ release include the presence of InsP(3)-Rs with varying sensitivities for InsP(3), heterogeneous InsP(3)R distribution, intrinsic inactivation of the InsP(3)Rs, and regulation of the InsP(3)Rs by Ca2+ store content. This article reviews critically the evidence for the various mechanisms and evaluates their functional importance. A Ca2+-mediated conformational change of the InsP(3)R is most likely the key feature of the mechanism for quantal Ca2+ release, but the exact mode of operation remains unclear. It should also be pointed out that in intact cells more than one mechanism can be involved.